Back

Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants

Russell, T. W.; Townsley, H.; Abbott, S.; Hellewell, J.; Carr, E. J.; Chapman, L.; Pung, R.; Quilty, B. J.; Hodgson, D.; Fowler, A.; Adams, L.; Bailey, C.; Mears, H. V.; Harvey, R.; Clayton, B.; O'Reilly, N.; Ngai, Y.; Nicod, J.; Gamblin, S.; Williams, B.; Gandhi, S.; Swanton, C.; Beale, R.; Bauer, D. L.; Wall, E. C.; Kucharski, A.

2023-05-24 epidemiology
10.1101/2023.05.17.23290105 medRxiv
Show abstract

The emergence of successive SARS-CoV-2 variants of concern (VOC) during 2020-22, each exhibiting increased epidemic growth relative to earlier circulating variants, has created a need to understand the drivers of such growth. However, both pathogen biology and changing host characteristics - such as varying levels of immunity - can combine to influence replication and transmission of SARS-CoV-2 within and between hosts. Disentangling the role of variant and host in individual-level viral shedding of VOCs is essential to inform COVID-19 planning and response, and interpret past epidemic trends. Using data from a prospective observational cohort study of healthy adult volunteers undergoing weekly occupational health PCR screening, we developed a Bayesian hierarchical model to reconstruct individual-level viral kinetics and estimate how different factors shaped viral dynamics, measured by PCR cycle threshold (Ct) values over time. Jointly accounting for both inter-individual variation in Ct values and complex host characteristics - such as vaccination status, exposure history and age - we found that age and number of prior exposures had a strong influence on peak viral replication. Older individuals and those who had at least five prior antigen exposures to vaccination and/or infection typically had much lower levels of shedding. Moreover, we found evidence of a correlation between the speed of early shedding and duration of incubation period when comparing different VOCs and age groups. Our findings illustrate the value of linking information on participant characteristics, symptom profile and infecting variant with prospective PCR sampling, and the importance of accounting for increasingly complex population exposure landscapes when analysing the viral kinetics of VOCs.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 23%
8.3%
2
eLife
5422 papers in training set
Top 10%
7.1%
3
PNAS Nexus
147 papers in training set
Top 0.1%
6.3%
4
Scientific Reports
3102 papers in training set
Top 26%
4.5%
5
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 16%
4.3%
6
Science Advances
1098 papers in training set
Top 4%
3.9%
7
Science
429 papers in training set
Top 9%
3.6%
8
Cell Genomics
162 papers in training set
Top 1%
3.6%
9
American Journal of Epidemiology
57 papers in training set
Top 0.3%
3.6%
10
Cell Reports
1338 papers in training set
Top 21%
2.1%
11
Journal of The Royal Society Interface
189 papers in training set
Top 2%
2.1%
12
iScience
1063 papers in training set
Top 12%
1.9%
50% of probability mass above
13
Nature
575 papers in training set
Top 10%
1.9%
14
PLOS Computational Biology
1633 papers in training set
Top 15%
1.9%
15
PLOS Genetics
756 papers in training set
Top 8%
1.8%
16
mSystems
361 papers in training set
Top 5%
1.7%
17
Viruses
318 papers in training set
Top 3%
1.7%
18
Epidemics
104 papers in training set
Top 1.0%
1.7%
19
Molecular Systems Biology
142 papers in training set
Top 0.6%
1.7%
20
Emerging Infectious Diseases
103 papers in training set
Top 2%
1.5%
21
Cell
370 papers in training set
Top 12%
1.5%
22
Nature Biotechnology
147 papers in training set
Top 5%
1.3%
23
The Journal of Infectious Diseases
182 papers in training set
Top 3%
1.3%
24
Virus Evolution
140 papers in training set
Top 0.9%
1.3%
25
Genome Medicine
154 papers in training set
Top 6%
1.2%
26
Nature Medicine
117 papers in training set
Top 3%
1.2%
27
Cell Reports Medicine
140 papers in training set
Top 5%
1.2%
28
Science Translational Medicine
111 papers in training set
Top 4%
1.2%
29
Clinical Infectious Diseases
231 papers in training set
Top 4%
1.1%
30
mBio
750 papers in training set
Top 10%
0.9%